In addition, sorafenib indirectly suppresses tumor cell proliferation through targeting c-Kit, FLT-3, VEGFR-2/3, PDGFR-β, and other tyrosine kinases, which are involved in tumor angiogenesis [3]. The gene discussed is KIT; the disease is neoplasm.